Miro1 R272Q disrupts mitochondrial calcium handling and neurotransmitter uptake in dopaminergic neurons

Lisa Schwarz1, Karan Sharma1, Lorenzo D Dodi1

  • 1Department of Neurodegenerative Diseases, Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany.

Insights

The Miro1 R272Q mutation disrupts mitochondrial calcium handling and function, impacting dopaminergic neurons. This finding is crucial for understanding Parkinson's disease development.

Area of Science:

  • Neuroscience
  • Cell Biology
  • Mitochondrial Biology

Background:

  • Miro1 (Rho GTPase) regulates mitochondrial distribution, calcium buffering, and mitophagy.
  • Miro1 variants, including R272Q, are found in Parkinson's disease patients.
  • The functional impact of the Miro1 R272Q mutation on dopaminergic function is unknown.

Purpose of the Study:

  • To investigate the functional consequences of the heterozygous Miro1 R272Q point mutation in dopaminergic neurons.
  • To determine the role of Miro1 R272Q in mitochondrial calcium regulation and overall neuronal function.

Main Methods:

  • Introduction of a heterozygous RHOT1/Miro1 R272Q point mutation into induced pluripotent stem cells.
  • Analysis of Miro1 protein levels, mitophagy, mitochondrial movement, and morphology in dopaminergic neurons.
  • Assessment of cytosolic calcium responses, mitochondrial respiration, and neurotransmitter uptake.

Main Results:

  • Miro1 R272Q did not alter Miro1 levels, mitophagy, or mitochondrial movement but caused mitochondrial fragmentation and reduced cristae/ATP5A.
  • The mutation impaired mitochondrial calcium buffering and cytosolic calcium responses.
  • Altered calcium handling correlated with reduced mitochondrial respiration, defective dopamine regulation, and impaired catecholamine uptake.

Conclusions:

  • The Miro1 R272Q mutation impairs mitochondrial calcium regulation and capacity at the outer membrane.
  • These mitochondrial defects are sufficient to disrupt dopaminergic neuron function.
  • The study highlights a novel mechanism linking Miro1 mutations to Parkinson's disease pathogenesis.